Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Phase II trial of neoadjuvant chemotherapy using alternating doublets in non-small-cell lung cancer.

Phase II trial of neoadjuvant chemotherapy using alternating doublets in non-small-cell lung cancer. Clin Lung Cancer. 2007 Jan; 8(4):257-63.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.